Identification of IL18RAP/IL18R1 and IL12B as leprosy risk genes demonstrates shared pathogenesis between inflammation and infectious diseases

American Journal of Human Genetics

Volumn 91, Issue 5, 2012, Pages 935-941

  Liu, Hong ^a,b,c,d   Irwanto, Astrid ^e,f   Tian, Hongqing ^a,d   Fu, Xi'An ^b,c   Yu, Yongxiang ^b,c   Yu, Gongqi ^b,c   Low, Huiqi ^e   Chu, Tongsheng ^b,c   Li, Yi ^e   Shi, Benqing ^a,d   Chen, Mingfei ^b,c   Sun, Yonghu ^b,c   Yuan, Chunying ^b,c   Lu, Nan ^b,c   You, Jiabao ^b,c   Bao, Fangfang ^b,c   Li, Jinghui ^b,c   Liu, Jian ^b,c   Liu, Huaxu ^b,c   Liu, Dianchang ^b,c   Yu, Xiulu ^b,c   Zhang, Lin ^b,c   Yang, Qing ^b,c   Wang, Na ^b,c   Niu, Guiye ^b,c   Ma, Shanshan ^b,c   Zhou, Yan ^b,c   Wang, Chuan ^b,c   Chen, Shumin ^b,c   Zhang, Xuejun ^g,h   Liu, Jianjun ^b,e,g   Zhang, Furen ^a,b,c,d,g   more..

^a SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c Shandong Provincial Key Lab for Dermatovenereology   (China)

^d Shandong Provincial Medical Center for Dermatovenereology   (China)

^e GENOME INSTITUTE OF SINGAPORE   (Singapore)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^g ANHUI MEDICAL UNIVERSITY   (China)

^h BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12P40; INTERLEUKIN 18; INTERLEUKIN 18RAP; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTERITIS; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; LEPROSY; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; POPULATION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATORY BOWEL DISEASES; INTERFERON-GAMMA; INTERLEUKIN-12 SUBUNIT P40; INTERLEUKIN-18 RECEPTOR ALPHA SUBUNIT; LEPROSY; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84868492064     PISSN: 00029297     EISSN: 15376605     Source Type: Journal    
DOI: 10.1016/j.ajhg.2012.09.010     Document Type: Article

References (38)

1. F.R. Zhang, H. Liu, S. Chen, H. Low, L. Sun, Y. Cui, T. Chu, Y. Li, X. Fu, and Y. Yu Identification of two new loci at IL23R and RAB32 that influence susceptibility to leprosy Nat. Genet. 43 2011 1247 1251
2. J.C. Barrett, S. Hansoul, D.L. Nicolae, J.H. Cho, R.H. Duerr, J.D. Rioux, S.R. Brant, M.S. Silverberg, K.D. Taylor, M.M. Barmada NIDDK IBD Genetics Consortium Belgian-French IBD Consortium Wellcome Trust Case Control Consortium Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease Nat. Genet. 40 2008 955 962
3. C.A. Anderson, G. Boucher, C.W. Lees, A. Franke, M. D'Amato, K.D. Taylor, J.C. Lee, P. Goyette, M. Imielinski, and A. Latiano Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47 Nat. Genet. 43 2011 246 252
4. R.P. Nair, K.C. Duffin, C. Helms, J. Ding, P.E. Stuart, D. Goldgar, J.E. Gudjonsson, Y. Li, T. Tejasvi, B.J. Feng Collaborative Association Study of Psoriasis Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways Nat. Genet. 41 2009 199 204
5. D.M. Evans, C.C. Spencer, J.J. Pointon, Z. Su, D. Harvey, G. Kochan, U. Oppermann, A. Dilthey, M. Pirinen, M.A. Stone Spondyloarthritis Research Consortium of Canada (SPARCC) Australo-Anglo-American Spondyloarthritis Consortium (TASC) Wellcome Trust Case Control Consortium 2 (WTCCC2) Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility Nat. Genet. 43 2011 761 767
6. V. Plagnol, J.M. Howson, D.J. Smyth, N. Walker, J.P. Hafler, C. Wallace, H. Stevens, L. Jackson, M.J. Simmonds, P.J. Bingley Type 1 Diabetes Genetics Consortium Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases PLoS Genet. 7 2011 e1002216
7. F.R. Zhang, W. Huang, S.M. Chen, L.D. Sun, H. Liu, Y. Li, Y. Cui, X.X. Yan, H.T. Yang, and R.D. Yang Genomewide association study of leprosy N. Engl. J. Med. 361 2009 2609 2618
8. C.W. Lees, J.C. Barrett, M. Parkes, and J. Satsangi New IBD genetics: Common pathways with other diseases Gut 60 2011 1739 1753
9. F. Coulombe, and M.A. Behr Crohn's disease as an immune deficiency? Lancet 374 2009 769 770
10. J.L. Casanova, and L. Abel Revisiting Crohn's disease as a primary immunodeficiency of macrophages J. Exp. Med. 206 2009 1839 1843
11. E.S. Pierce Where are all the Mycobacterium avium subspecies paratuberculosis in patients with Crohn's disease? PLoS Pathog. 5 2009 e1000234
12. M.A. Behr, and E. Schurr Mycobacteria in Crohn's disease: A persistent hypothesis Inflamm. Bowel Dis. 12 2006 1000 1004
13. R.L. Modlin Th1-Th2 paradigm: Insights from leprosy J. Invest. Dermatol. 102 1994 828 832
14. A. Castellanos-Rubio, I. Santin, I. Irastorza, L. Castaño, J. Carlos Vitoria, and J. Ramon Bilbao TH17 (and TH1) signatures of intestinal biopsies of CD patients in response to gliadin Autoimmunity 42 2009 69 73
15. F. Heller, P. Florian, C. Bojarski, J. Richter, M. Christ, B. Hillenbrand, J. Mankertz, A.H. Gitter, N. Bürgel, and M. Fromm Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution Gastroenterology 129 2005 550 564
16. M.F. Moffatt, I.G. Gut, F. Demenais, D.P. Strachan, E. Bouzigon, S. Heath, E. von Mutius, M. Farrall, M. Lathrop, W.O. Cookson GABRIEL Consortium A large-scale, consortium-based genomewide association study of asthma N. Engl. J. Med. 363 2010 1211 1221
17. P.C. Dubois, G. Trynka, L. Franke, K.A. Hunt, J. Romanos, A. Curtotti, A. Zhernakova, G.A. Heap, R. Adány, and A. Aromaa Multiple common variants for celiac disease influencing immune gene expression Nat. Genet. 42 2010 295 302
18. K.A. Hunt, A. Zhernakova, G. Turner, G.A. Heap, L. Franke, M. Bruinenberg, J. Romanos, L.C. Dinesen, A.W. Ryan, and D. Panesar Newly identified genetic risk variants for celiac disease related to the immune response Nat. Genet. 40 2008 395 402
19. M. Parkes, J.C. Barrett, N.J. Prescott, M. Tremelling, C.A. Anderson, S.A. Fisher, R.G. Roberts, E.R. Nimmo, F.R. Cummings, D. Soars Wellcome Trust Case Control Consortium Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility Nat. Genet. 39 2007 830 832
20. N.A. Patsopoulos, F. Esposito, J. Reischl, S. Lehr, D. Bauer, J. Heubach, R. Sandbrink, C. Pohl, G. Edan, L. Kappos Bayer Pharma MS Genetics Working Group Steering Committees of Studies Evaluating IFNβ-1b and a CCR1-Antagonist ANZgene Consortium GeneMSA International Multiple Sclerosis Genetics Consortium Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci Ann. Neurol. 70 2011 897 912
21. E. Ellinghaus, D. Ellinghaus, P.E. Stuart, R.P. Nair, S. Debrus, J.V. Raelson, M. Belouchi, H. Fournier, C. Reinhard, and J. Ding Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2 Nat. Genet. 42 2010 991 995
22. X.J. Zhang, W. Huang, S. Yang, L.D. Sun, F.Y. Zhang, Q.X. Zhu, F.R. Zhang, C. Zhang, W.H. Du, and X.M. Pu Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21 Nat. Genet. 41 2009 205 210
23. U. Hüffmeier, S. Uebe, A.B. Ekici, J. Bowes, E. Giardina, E. Korendowych, K. Juneblad, M. Apel, R. McManus, and P. Ho Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis Nat. Genet. 42 2010 996 999
24. J. Schmitz, A. Owyang, E. Oldham, Y. Song, E. Murphy, T.K. McClanahan, G. Zurawski, M. Moshrefi, J. Qin, and X. Li IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines Immunity 23 2005 479 490
25. H. Hayakawa, M. Hayakawa, A. Kume, and S. Tominaga Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation J. Biol. Chem. 282 2007 26369 26380
26. V.E. García, K. Uyemura, P.A. Sieling, M.T. Ochoa, C.T. Morita, H. Okamura, M. Kurimoto, T.H. Rea, and R.L. Modlin IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection J. Immunol. 162 1999 6114 6121
27. K. Kobayashi, M. Kai, M. Gidoh, N. Nakata, M. Endoh, R.P. Singh, T. Kasama, and H. Saito The possible role of interleukin (IL)-12 and interferon-gamma-inducing factor/IL-18 in protection against experimental Mycobacterium leprae infection in mice Clin. Immunol. Immunopathol. 88 1998 226 231
28. Q. Guan, Y. Ma, C.L. Hillman, G. Qing, A.G. Ma, C.R. Weiss, G. Zhou, A. Bai, R.J. Warrington, C.N. Bernstein, and Z. Peng Targeting IL-12/IL-23 by employing a p40 peptide-based vaccine ameliorates TNBS-induced acute and chronic murine colitis Mol. Med. 17 2011 646 656
29. G. Morahan, G. Kaur, M. Singh, C.C. Rapthap, N. Kumar, K. Katoch, N.K. Mehra, and D. Huang Association of variants in the IL12B gene with leprosy and tuberculosis Tissue Antigens 69 Suppl 1 2007 234 236
30. H.W. Tso, Y.L. Lau, C.M. Tam, H.S. Wong, and A.K. Chiang Associations between IL12B polymorphisms and tuberculosis in the Hong Kong Chinese population J. Infect. Dis. 190 2004 913 919
31. X. Ma, R.A. Reich, O. Gonzalez, X. Pan, A.K. Fothergill, J.R. Starke, L.D. Teeter, J.M. Musser, and E.A. Graviss No evidence for association between the polymorphism in the 3′ untranslated region of interleukin-12B and human susceptibility to tuberculosis J. Infect. Dis. 188 2003 1116 1118
32. A. Bafica, C.A. Scanga, C.G. Feng, C. Leifer, A. Cheever, and A. Sher TLR9 regulates Th1 responses and cooperates with TLR2 in mediating optimal resistance to Mycobacterium tuberculosis J. Exp. Med. 202 2005 1715 1724
33. S.A. Khader, S. Partida-Sanchez, G. Bell, D.M. Jelley-Gibbs, S. Swain, J.E. Pearl, N. Ghilardi, F.J. Desauvage, F.E. Lund, and A.M. Cooper Interleukin 12p40 is required for dendritic cell migration and T cell priming after Mycobacterium tuberculosis infection J. Exp. Med. 203 2006 1805 1815
34. H. Schindler, M.B. Lutz, M. Röllinghoff, and C. Bogdan The production of IFN-gamma by IL-12/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4 J. Immunol. 166 2001 3075 3082
35. S. Coimbra, A. Figueiredo, E. Castro, P. Rocha-Pereira, and A. Santos-Silva The roles of cells and cytokines in the pathogenesis of psoriasis Int. J. Dermatol. 51 2012 389 395 quiz 395-398
36. S.T. Leach, I. Messina, D.A. Lemberg, D. Novick, M. Rubenstein, and A.S. Day Local and systemic interleukin-18 and interleukin-18-binding protein in children with inflammatory bowel disease Inflamm. Bowel Dis. 14 2008 68 74
37. T.T. Pizarro, M.H. Michie, M. Bentz, J. Woraratanadharm, M.F. Smith Jr., E. Foley, C.A. Moskaluk, S.J. Bickston, and F. Cominelli IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: Expression and localization in intestinal mucosal cells J. Immunol. 162 1999 6829 6835
38. P.V. Sivakumar, G.M. Westrich, S. Kanaly, K. Garka, T.L. Born, J.M. Derry, and J.L. Viney Interleukin 18 is a primary mediator of the inflammation associated with dextran sulphate sodium induced colitis: Blocking interleukin 18 attenuates intestinal damage Gut 50 2002 812 820